APA (7th ed.) Citation

Attalla, S. A., Isaac, K. J., Pfeffer, M., Hockaday, J. R., Weatherly, R., Asselin, M. B., . . . Ellis, B. L. (2026). Mass drug administration approved and candidate anthelmintics beginning on larval stage 1 Caenorhabditis elegans are generally potent, suggesting a novel, pre-infective control for helminths. PLoS ONE, 21(4), 1. https://doi.org/10.1371/journal.pone.0346795

Chicago Style (17th ed.) Citation

Attalla, Sam A., et al. "Mass Drug Administration Approved and Candidate Anthelmintics Beginning on Larval Stage 1 Caenorhabditis Elegans Are Generally Potent, Suggesting a Novel, Pre-infective Control for Helminths." PLoS ONE 21, no. 4 (2026): 1. https://doi.org/10.1371/journal.pone.0346795.

MLA (9th ed.) Citation

Attalla, Sam A., et al. "Mass Drug Administration Approved and Candidate Anthelmintics Beginning on Larval Stage 1 Caenorhabditis Elegans Are Generally Potent, Suggesting a Novel, Pre-infective Control for Helminths." PLoS ONE, vol. 21, no. 4, 2026, p. 1, https://doi.org/10.1371/journal.pone.0346795.

Warning: These citations may not always be 100% accurate.